Cypermethrin alters the expression profile of mrnas in the adult rat striatum: A putative mechanism of postnatal pre-exposure followed by adulthood re-exposure-enhanced neurodegeneration

Neurotoxicity Research

Volumn 22, Issue 4, 2012, Pages 321-334

  Tiwari, Manindra Nath ^a   Singh, Anand Kumar ^a   Agrawal, Sonal ^a   Gupta, Satya Prakash ^a   Jyoti, Anurag ^a   Shanker, Rishi ^a   Prakash, Om ^b   Singh, Mahendra Pratap ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cypermethrin; Microarray; Nigrostriatal dopaminergic neurodegeneration; Parkinson's disease; Striatum

Indexed keywords

APC PROTEIN; B RAF KINASE; BETA6 INTEGRIN; CASPASE 9; CIPERMETHRIN; CYCLIN A2; CYCLIN D2; CYCLIN DEPENDENT KINASE 9; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLIN DEPENDENT KINASE INHIBITOR 2D; CYTOCHROME C; DEATH ASSOCIATED PROTEIN KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 9; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 4; PRESENILIN 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN KINASE B; PROTEIN P53; SOMATOMEDIN C; STAT4 PROTEIN; STAT5A PROTEIN;

ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIVISION; CELL METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; DNA REPAIR; DOWN REGULATION; DRUG REEXPOSURE; GENE CLUSTER; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICROARRAY ANALYSIS; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRIATONIGRAL DEGENERATION; UPREGULATION; WESTERN BLOTTING;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL CYCLE; CORPUS STRIATUM; CYTOCHROMES C; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INSECTICIDES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PYRETHRINS; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MURINAE; RATTUS;

EID: 84870299930     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-012-9317-8     Document Type: Article

References (53)

1. Anadon A, Martinez-Larranaga MR, Fernandiz-Cruz ML, Diaz MJ, Fernandiz MC, Martinez MA (1996) Toxicokinetics of deltamethrin and 4'-HO-metabolite in the rat. Toxicol Appl Pharmacol 141:8-16
2. Andrews ZB, Horvath B, Barnstable CJ, Elseworth J, Yang L, Beal MF, Roth RH, Matthews RT, Horvath TL (2005) Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. J Neurosci 25:184-191
3. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndrome of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415-455
4. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Alexander V, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306
5. Bianco F, Pravettoni E, Colombo A, Schenk U, Moller T, Matteoli M, Verderio C (2005) Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J Immunol 174: 7268-7277
6. Breese MH (1977) The potential for pyrethroids as agricultural, veterinary and industrial insecticides. Pestic Sci 8:264-269
7. Butler TL, Kassed CA, Sanberg PR, Willing AE, Pennypacker KR (2002) Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res 929:252-260
8. Chugh Y, Sankaranarayanan A, Sharma PL (1992) MK-801 antagonizes the lethal action of centrally and peripherally administered cypermethrin in mice and rats. J Pharm Pharmacol 44:521-523
9. Crawford MJ, Croucher A, Hutson DH (1981) Metabolism of cis- and trans-cypermethrin in rats: balance and tissue retention study. J Agr Food Chem 29:130-135
10. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31:19-20
11. Dayal M, Parmar D, Dhawan A, Ali M, Dwivedi UN, Seth PK (2003) Effect of pretreatment of cytochrome P450 (P450) modifiers on neurobehavioral toxicity induced by deltamethrin. Food Chem Toxicol 41:431-437
12. DiMonte DA (2003) The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol 2:531-538
13. Dobbing J (1975) Prenatal nutrition and neurological development. UCLA Forum Med Sci 18:401-420
14. Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci 98:14669-14674
15. Giray B, Gurbay A, Hincal F (2001) Cypermethrin-induced oxidative stress in rat brain and liver is prevented by vitamin E or allopurinol. Toxicol Lett 118:139-146
16. Gomez-Lechon MJ, O'Connor JE, Lohoz A, Castell JV, Donato MT (2008) Identification of apoptotic drugs: multi-parametric evaluation in cultured hepatocytes. Curr Med Chem 15:2071-2085
17. Gupta A, Agarwal AK, Shukla GS (2000) Effect of quinalphos and cypermethrin exposure on developing blood-brain barrier: role of nitric oxide. Environ Toxicol Pharmacol 8:73-78
18. Imamura L, Hasegawa H, Kurashina K, Hamanishi A, Tabuchi A, Tsuda M (2000) Repression of activity-dependent c-fos and brain-derived neurotrophic factor mRNA expression by pyrethroid insecticides accompanying a decrease in Ca (2+) influx into neurons. J Pharmacol Exp Ther 295:1175-1182
19. Jin Y, Zheng S, Pu Y, Shu L, Sun L, Liu W, Fu Z (2011) Cypermethrin has the potential to induce hepatic oxidative stress, DNA damage and apoptosis in adult zebrafish (Danio rerio). Chemosphere 82:398-404
20. Kroemer G, Zamazami N, Susin SA (1997) Mitochondrial control of apoptosis. Immunol Today 18:44-51
21. Kumar A, Ahmed I, Shukla S, Singh BK, Patel DK, Pandey HP, Singh C (2010) Effect of zinc and paraquat co-exposure on neurodegeneration: modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats. Free Radic Res 44:950-965
22. Lajtha A, Dunlop D (1981) Turnover of protein in the nervous system. Life Sci 29:755-767
23. Li B, Xu W, Luo C, Gozal D, Liu R (2003) VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Molecular Brain Res 111:155-164
24. Liu B, Gao HM, Hong JS (2003) Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect 111:1065-1073
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
26. Malaviya M, Husain R, Seth PK, Husain R (1993) Perinatal effects of two pyrethroid insecticides on brain neurotransmitter function in the neonatal rat. Vet Hum Toxicol 35:119-122
27. Marks N, Berg MJ (1999) Recent advances on neuronal caspases in development and neurodegeneration. Neurochem Int 35:195-220
28. Miller RL, James-Kracke M, Sun GY, Sun AY (2009) Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res 34:55-65
29. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994) Tumor suppressor p53 is a regulator of Bcl-2 and Bax gene expression in vitro and in vivo. Oncogene 9:1799-1805
30. Mun JY, Lee WY, Han SS (2005) Effects of cypermethrin on the dopaminergic neurons in the progressive hemiparkinsonian rats. Toxicol Mech Methods 15:399-404
31. Nasuti C, Gabbianelli R, Falcioni ML, Di Stefano A, Sozio P, Cantalamessa F (2007) Dopaminergic system modulation, behavioral changes and oxidative stress after neonatal administration of pyrethroids. Toxicology 229:194-205
32. Parkinson A (2001) Biotransformation of xenobiotics, Casarett and Doull's Toxicology. In: Klaassen CD (ed) The basic sciences of poison. McGraw Hill, New York, pp 133-224
33. Patel S, Pandey A, Bajpayee M, Parmar D, Dhawan A (2006a) Cypermethrin-induced DNA damage in organs and tissues of the mouse: evidence from the comet assay. Mutat Res 607:176-183
34. Patel S, Singh V, Kumar A, Gupta YK, Singh MP (2006b) Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration. Brain Res 1081:9-18
35. Patel S, Singh K, Singh S, Singh MP (2008) Gene expression profiles of mouse striatum in control and maneb ? paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts. Mol Biotechnol 40:59-68
36. Pearson VL, Rothwell NJ, Toulmond S (1999) Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia 25:311-323
37. Pitzer MR, Sortwell CE, Daley BF, McGuire SO, Marchionini D, Fleming M, Collier TJ (2003) Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells. Exp Neurol 182:435-445
38. Robert M, Friedlander MD (2003) Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 348:1365-1375
39. Saint-Pierre M, Tremblay M, Sik A, Gross RE, Cicchetti F (2006) Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats. J Neurochem 98:760-772
40. Silverman WF, Krum JM, Mani N, Rosenstein JM (1999) Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience 90:1529-1541
41. Singh K, Singh S, Singhal NK, Sharma A, Parmar D, Singh MP (2010) Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: implications in neuroprotection mechanism. Chem Biol Interact 185:81-93
42. Singh AK, Tiwari MN, Dixit A, Upadhyay G, Patel DK, Singh D, Prakash O, Singh MP (2011) Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation dependent and independent regulations. Toxicol Sci 122:526-538
43. Singh AK, Tiwari MN, Upadhyay G, Patel DK, Singh D, Prakash O, Singh MP (2012) Long-term exposure to cypermethrin induces the nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol Aging 33:404-415
44. Soh Y, Rhe HM, Sohn DH, Song BJ (1996) Immunological detection of CYP2E1 in fresh rat lymphocytes and its pretranslational induction by fasting. Biochem Biophys Res Commun 227:541-546
45. Sun FY, Guo X (2005) Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res 79:180-184
46. Tiwari MN, Singh AK, Ahmed I, Upadhyay G, Singh D, Patel DK, Singh C, Prakash O, Singh MP (2010) Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system. Free Radic Res 44:1416-1424
47. Upadhyay G, Tiwari MN, Prakash O, Jyoti A, Shanker R, Singh MP (2010) Involvement of multiple molecular events in pyrogallolinduced hepatotoxicity and silymarin-mediated protection: evidence from gene expression profiles. Food Chem Toxicol 48: 1660-1670
48. Veldman BA, Wijn AM, Knoers N, Praamstra P, Horstink MW (1998) Genetic and environmental risk factors in Parkinson's disease. Clin Neurol Neurosurg 100:15-26
49. Walker AP, Bacherald HS (1988) Studies on DNA damage and repair in mammalian brain. J Neurochem 51:1394-1399
50. Wu A, Li L, Liu Y (2003) Deltamethrin induces apoptotic cell death in cultured cerebral cortical neurons. Toxicol Appl Pharmacol 187:50-57
51. Xiang H, Kinoshita Y, Knudson CM, Korsmeyer SJ, Schwartzkroin PA, Morrison RS (1998) Bax involvement in p53-mediated neuronal cell death. J Neurosci 18:1363-1373
52. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132
53. Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, Matsui T, Miyoshi Y, Hamada H, Date I (2004) Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci 19:1494-1504